Claims
- 1. A method of treating cancer which comprises administering to a patient a pharmaceutically acceptable amount of a chimeric antibody produced by a transformant KM-871 (FERM BP-35 12) which is reactive with ganglioside GD.sub.3.
Priority Claims (1)
Number |
Date |
Country |
Kind |
HEI-3-238375 |
Sep 1991 |
JPX |
|
Parent Case Info
This is a Divisional of application Ser. No. 08/408,133, filed Mar. 21, 1995, which is a Rule 62 Continuation of application Ser. No. 08/292,178, filed Aug. 17, 1994, now abandoned, which in turn is a Rule 62 Continuation of application Ser. No. 07/947,674, filed Sep. 17, 1992, now abandoned.
Foreign Referenced Citations (9)
Number |
Date |
Country |
0 171 496 |
Feb 1986 |
EPX |
0 173 494 |
Mar 1986 |
EPX |
0 255 694 |
Feb 1988 |
EPX |
0 266 663 |
May 1988 |
EPX |
0 267 615 |
May 1988 |
EPX |
0 314 161 |
May 1989 |
EPX |
0 332 879 |
Sep 1989 |
EPX |
0 493 686 |
Jul 1992 |
EPX |
0239400 |
Sep 1997 |
EPX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
408133 |
Mar 1995 |
|
Continuations (2)
|
Number |
Date |
Country |
Parent |
292178 |
Aug 1994 |
|
Parent |
947674 |
Sep 1992 |
|